Literature DB >> 10071562

Response of carcinoma of the prostate to withdrawal of flutamide.

M P Collinson1, F Daniel, C J Tyrrell, C Teasdale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 10071562     DOI： 10.1111/j.1464-410x.1993.tb16234.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  4 in total

Review 1.  Bicalutamide in advanced prostate cancer. A review.

Authors:  K L Goa; C M Spencer
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

Review 2.  Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significance.

Authors:  R Paul; J Breul
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 3.  Blockade of testicular and adrenal androgens in prostate cancer treatment.

Authors:  Fernand Labrie
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

4.  A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.

Authors:  Yiu-Keung Lau; Manpreet K Chadha; Alan Litwin; Donald L Trump
Journal:  J Hematol Oncol       Date:  2008-11-05       Impact factor: 17.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.